QQQ   430.00 (-0.25%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.75 (-3.60%)
BABA   69.67 (-1.35%)
T   16.07 (-1.05%)
F   11.99 (-1.96%)
MU   119.20 (-1.79%)
GE   153.95 (+0.16%)
CGC   6.69 (-4.15%)
DIS   112.79 (-0.14%)
AMC   2.48 (+0.40%)
PFE   25.87 (-0.15%)
PYPL   62.96 (-0.87%)
XOM   119.16 (-0.43%)
QQQ   430.00 (-0.25%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.75 (-3.60%)
BABA   69.67 (-1.35%)
T   16.07 (-1.05%)
F   11.99 (-1.96%)
MU   119.20 (-1.79%)
GE   153.95 (+0.16%)
CGC   6.69 (-4.15%)
DIS   112.79 (-0.14%)
AMC   2.48 (+0.40%)
PFE   25.87 (-0.15%)
PYPL   62.96 (-0.87%)
XOM   119.16 (-0.43%)
QQQ   430.00 (-0.25%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.75 (-3.60%)
BABA   69.67 (-1.35%)
T   16.07 (-1.05%)
F   11.99 (-1.96%)
MU   119.20 (-1.79%)
GE   153.95 (+0.16%)
CGC   6.69 (-4.15%)
DIS   112.79 (-0.14%)
AMC   2.48 (+0.40%)
PFE   25.87 (-0.15%)
PYPL   62.96 (-0.87%)
XOM   119.16 (-0.43%)
QQQ   430.00 (-0.25%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.75 (-3.60%)
BABA   69.67 (-1.35%)
T   16.07 (-1.05%)
F   11.99 (-1.96%)
MU   119.20 (-1.79%)
GE   153.95 (+0.16%)
CGC   6.69 (-4.15%)
DIS   112.79 (-0.14%)
AMC   2.48 (+0.40%)
PFE   25.87 (-0.15%)
PYPL   62.96 (-0.87%)
XOM   119.16 (-0.43%)

eFFECTOR Therapeutics (EFTR) SEC Filings & 10K Form

$1.92
-0.01 (-0.52%)
(As of 09:52 AM ET)

Recent eFFECTOR Therapeutics SEC Filings

DateFilerForm TypeView
04/04/2024
7:38 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
7:40 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B3
04/04/2024
7:15 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B5
04/02/2024
11:15 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form EFFECT
03/29/2024
1:51 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form POS AM
03/28/2024
3:02 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/26/2024
7:57 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/25/2024
3:10 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
4:39 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Loewy Caroline M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
4:20 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Harrington-Smith Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
4:22 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Klencke Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
4:25 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Ehrlich Christopher B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
4:27 PM
Bhatt Elizabeth (Reporting)
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
2:48 PM
eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
PFIZER INC (Filed by)
Form SC 13G/A
02/14/2024
8:48 AM
eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
SECTORAL ASSET MANAGEMENT INC (Filed by)
Form SC 13G/A
02/09/2024
7:14 PM
eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
SR ONE CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G/A
01/30/2024
7:31 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2024
7:01 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2024
7:06 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B3
01/08/2024
7:19 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B3
01/08/2024
7:15 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2023
7:23 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2023
7:23 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2023
7:31 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B3
12/08/2023
7:31 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B3
11/29/2023
4:07 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
George Simeon (Reporting)
SR One Capital Fund I Aggregator LP (Reporting)
SR ONE CAPITAL MANAGEMENT, LLC (Reporting)
SR ONE CAPITAL PARTNERS I, LP (Reporting)
SR One Co-Invest I Manager, LLC (Reporting)
SR One Co-Invest I, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2023
7:15 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2023
7:18 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B3
11/22/2023
3:16 PM
COLUMN GROUP II, LP (Filed by)
eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
Form SC 13D/A
11/16/2023
4:30 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
WORLAND STEPHEN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
4:26 PM
Byrnes Michael (Reporting)
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
3:33 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B3
11/13/2023
3:23 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
3:25 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/15/2023
3:05 PM
COLUMN GROUP II, LP (Filed by)
eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
Form SC 13D/A
09/11/2023
6:36 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Loewy Caroline M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/11/2023
6:38 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Loewy Caroline M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
3:58 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B3
09/11/2023
3:51 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/18/2023
3:16 PM
Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
Form SC 13D/A
08/14/2023
7:00 AM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
WORLAND STEPHEN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s “Tax Free” Retirement Strategy (Ad)

Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.

Protect your retirement savings from the inevitable devaluation of the dollar…
06/26/2023
11:15 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form EFFECT
06/22/2023
7:10 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Gallagher Brian M. Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
7:12 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Harrington-Smith Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
7:14 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Klencke Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
7:16 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Smither John W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
7:04 PM
Bhatt Elizabeth (Reporting)
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
7:09 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Ehrlich Christopher B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
5:06 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2023
5:10 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B3
06/16/2023
3:53 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/08/2023
5:06 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B5
06/08/2023
5:11 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2023
5:14 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B3
05/30/2023
3:29 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B3
05/30/2023
3:18 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B5
05/25/2023
4:01 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/25/2023
4:06 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B3
05/19/2023
4:15 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2023
4:20 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B3
05/16/2023
7:01 AM
Byrnes Michael (Reporting)
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2023
7:03 AM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
WORLAND STEPHEN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2023
3:17 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:EFTR) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners